Kuros Biosciences Ltd. Logo

Kuros Biosciences Ltd.

Biologic tech for predictable spinal fusions, featuring the MagnetOs bone graft.

KURN | SW

Overview

Corporate Details

ISIN(s):
CH0325814116
LEI:
5299006U5POB2AVTT709
Country:
Switzerland
Address:
Wagisstraße 25, 8952 Schlieren
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Kuros Biosciences is a medical technology company that discovers, develops, and delivers innovative biologic technologies for tissue repair and bone regeneration. The company's primary focus is on improving outcomes in spinal fusion surgery to address high rates of failed fusions. Its main product is MagnetOs, a bone graft featuring proprietary NeedleGrip™ surface technology, which is designed to grow bone even in soft tissues for more predictable fusions. Kuros Biosciences supports its products through 'Project Fusion,' a global research program that combines scientific, pre-clinical, and clinical studies. The company operates globally with a commercial and research footprint across three continents and more than 20 markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-18 02:00
Legal Proceedings Report
Kuros statement on media inquiry concerning former Board member
English 7.6 KB
2025-09-04 02:00
Board/Management Information
Kuros Biosciences announces changes in the Board of Directors
English 7.4 KB
2025-08-14 02:00
Earnings Release
Kuros Biosciences Reports First Half of 2025 Results
English 22.7 KB
2025-03-11 01:00
Earnings Release
Kuros Biosciences grows sales to CHF 75.6 million for 2024
English 19.2 KB
2025-01-08 07:00
Legal Proceedings Report
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
English 13.7 KB
2025-01-07 07:00
Regulatory News Service
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
English 13.7 KB
2025-01-07 01:00
M&A Activity
Kuros Biosciences USA, Inc. announces an exclusive strategic agreement with the…
English 11.8 KB
2024-11-19 07:00
Board/Management Information
Kuros Biosciences Expands into Extremities Markets
English 18.5 KB
2024-11-19 01:00
Board/Management Information
Kuros Biosciences Expands into Extremities Markets
English 16.1 KB
2024-10-10 02:00
Earnings Release
Kuros reports 149% increase in direct MagnetOs sales and exceeds cash flow brea…
English 16.3 KB
2024-08-08 07:00
Earnings Release
Kuros Biosciences Reports First Half of 2024 Results
English 37.6 KB
2024-08-08 02:00
Earnings Release
Kuros Biosciences Reports First Half of 2024 Results
English 33.0 KB
2024-06-25 07:00
Regulatory News Service
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
English 17.2 KB
2024-06-25 02:00
Regulatory News Service
Kuros Biosciences Announces Peer-Reviewed Publication of MagnetOs MAXA Level 1 …
English 14.9 KB
2024-04-24 07:00
Earnings Release
Kuros reports Corporate Highlights as of Q1 2024 including increase in direct M…
English 17.0 KB

Automate Your Workflow. Get a real-time feed of all Kuros Biosciences Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Kuros Biosciences Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-23 N/A Executive member Sell None 1,264,800.00 CHF
2025-04-17 N/A Executive member Sell None 13,344.49 CHF
2025-03-18 N/A Non-Executive member Buy None 38,200.00 CHF
2024-12-11 N/A Executive member Sell None 4,702,500.00 CHF
2024-11-15 N/A Non-Executive member Buy None 925,210.00 CHF
2024-11-14 N/A Non-Executive member Sell None 592,000.00 CHF
2024-11-12 N/A Executive member Sell None 13,890.86 CHF
2024-09-25 N/A Executive member Sell None 8,226,000.00 CHF
2024-09-25 N/A Non-Executive member Sell None 3,656,000.00 CHF
2024-09-24 N/A Non-Executive member Buy None 223,720.00 CHF

Peer Companies

Company Country Ticker View
3-D Matrix,Ltd. Logo
Develops peptide-based medical devices for surgical bleeding control and wound healing.
Japan 7777
aap Implantate AG Logo
Develops and markets orthopedic trauma implants and plating systems for fracture treatment globally.
Germany AAQ1
ABL Diagnostics Logo
Develops integrated diagnostic solutions for infectious diseases for labs, clinicians, & researchers.
France ABLD
ADVANCED MEDICAL SOLUTIONS GROUP PLC Logo
Develops and manufactures innovative tissue-healing technologies for wound care and surgery.
United Kingdom AMS
Affluent Medical Logo
Developing minimally invasive, restorative implants for structural heart disease and urology.
France AFME
AIOBIO Co., Ltd. Logo
Develops AI biofluorescence dental tools for early detection of caries and plaque.
South Korea 447690
Airway Medix S.A. Logo
Develops single-use devices for mechanically ventilated patients in ICUs and anesthesiology.
Poland AWM
Alcon AG Logo
Global leader in eye care, offering surgical equipment, contact lenses, and ocular health products.
Switzerland ALC
Aligned Genetics, Inc. Logo
Develops advanced equipment for cell imaging and diagnostics for research & medicine.
South Korea 238120
Allmed Solutions Ltd. Logo
Develops, manufactures, and markets minimally invasive medical devices and solutions globally.
Israel ALMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.